31 July 2017 EMA/466502/2017 Human Medicines Research and Development Support Division

Organising committee - Joint BWP/QWP workshop with stakeholders in relation to prior knowledge and its use in regulatory applications 23 November 2017, European Medicines Agency, London

Name

Affiliation

Mats Welin (chair)

BWP Member, Sweden

Martijn van der Plas

BWP Alternate, The Netherlands

Nanna Kruse

BWP Member / Vice-Chair, Denmark

Sean Barry

BWP Alternate, Ireland

Sol Ruiz

BWP Member / Chair, CHMP Member, Spain

Keith Pugh

QWP Member / Chair, United Kingdom

Susanne Stotter

QWP Member, Austria

Brian Dooley

Quality Office, EMA

Veronika Jekerle

Quality Office, EMA

Markus Goese

EBE / Roche

Andrew Lennard

EBE / Amgen

Ronald Imhoff

EBE / Janssen Biologics

David Tainsh

EFPIA / GSK

Isabelle Colmagne-Poulard

EFPIA / Merck group

Keith Watson

EFPIA / Abbvie

Thomas Stangler

Medicines for Europe / Novartis

Koen Nauwelaerts

Medicines for Europe

Nancy Cauwenberghs

Vaccines Europe / MSD Inc

Audrey Brussel

IPFA / LFB-Biotechnologies

CHMP BWP QWP EBE EFPIA IPFA

-

Committee for Medicinal Products for Human Use Biologicals Working Party Quality Working Party European Biopharmaceutical Enterprises European Federation of Pharmaceutical Industries and Associations International plasma fractionation association

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

An agency of the European Union

© European Medicines Agency, 2017. Reproduction is authorised provided the source is acknowledged.

Organising committee - European Medicines Agency - Europa EU

Jul 31, 2017 - 30 Churchill Place ○ Canary Wharf ○ London E14 5EU ○ United Kingdom ... Human Medicines Research and Development Support Division.

121KB Sizes 0 Downloads 91 Views

Recommend Documents

Emtriva - European Medicines Agency - Europa EU
Emtriva is available as capsules (200 mg) and as a solution (10 mg/ml) to be taken by ... The Committee recommended that it be given marketing authorisation.

July 2016 - European Medicines Agency - Europa EU
Jul 11, 2016 - EMA/COMP/451206/2016 ... Cannabidiol for treatment of graft-versus-host disease, Richardson Associates Regulatory ..... Best Regulatory.

EVDAS - European Medicines Agency - Europa EU
EudraVigilance Data Analysis System (EVDAS) users ... Advanced Accelerator Applications ..... ACOM ADVANCED CENTER ONCOLOGY MACERATA SRL.

February 2017 - European Medicines Agency - Europa EU
Mar 16, 2017 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

October 2016 - European Medicines Agency - Europa EU
Nov 15, 2016 - Information Management Division ... This document provides current information related to the volume and evaluation of .... Plasma master file.

Mycophenolic acid - European Medicines Agency - Europa EU
Dec 1, 2016 - Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5525. Send a question via our ... List of nationally authorised medicinal products.

July 2016 - European Medicines Agency - Europa EU
Information is selected based on recommendations from consulted patients, consumers ... need one of the following: a modern web browser; a web-based news reader or a ..... person developing the medicine must submit an application to the.

everolimus - European Medicines Agency - Europa EU
Mar 31, 2016 - Procedure Management and Committees Support. List of nationally ...... LIMITED (ART57). UK. Certican 0.25 mg tabletti SE/H/0356/001. 18698.